Mouse Anti-LOXL2 Recombinant Antibody (HPAB-0160-LSX)

CAT#: HPAB-0160-LSX

This product is a recombinant mouse antibody that recognizes LOXL2. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Gene Expression
Figure 1 IF staining of human cell line U-2 OS Figure 2 IF staining of human cell line A549 Figure 3 IHC staining of human pancreas Figure 4 IF staining of human cell line U-251 MG Figure 5 Cerebral cortex Figure 6 Colon Figure 7 Liver Figure 8 Testis Figure 9 Placenta Figure 10 RNA cell line category: Cell line enhanced (BJ, BJ hTERT+ SV40 Large T+ RasG12V, fHDF/TERT166, TIME, U-87 MG)

Specifications

  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • Mouse IgG
  • Specificity
  • Human LOXL2
  • Species Reactivity
  • Human
  • Applications
  • ELISA
  • Related Disease
  • Fibrotic condition

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • LOR2; WS9-14
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for HPAB-0160-LSX. Click the button above to contact us or submit your feedback about this product.

Citations

  1. Fan, Zhiyong, et al. "LOXL2 upregulates hypoxia-inducible factor-1α signaling through Snail-FBP1 axis in hepatocellular carcinoma cells." Oncology reports 43.5 (2020): 1641-1649. https://doi.org/10.3892/or.2020.7541
    This research investigates the role of Lysyl oxidase-like 2 (LOXL2) in hepatocellular carcinoma (HCC) progression, focusing on its regulatory effect on hypoxia-inducible factor-1α (HIF-1α) signaling. The study demonstrates that LOXL2 inhibits the expression of fructose-1,6-biphosphatase (FBP1) in a Snail-dependent manner, which subsequently enhances glycolysis in HCC cell lines. Importantly, the research reveals that intracellular LOXL2 activity, rather than extracellular LOXL2, is responsible for upregulating HIF-1α/VEGF signaling pathways through the Snail-FBP1 axis. This effect was abolished when using LOXL2 inhibitors, suggesting therapeutic potential.
    Creative Biolabs provided an anti-human LOXL2 therapeutic antibody (Simtuzumab; CAT#: HPAB-0160-LSX) that was used to evaluate the binding between the antibody and extracellular LOXL2 protein in immunoprecipitation assays. This antibody helped researchers distinguish between the roles of intracellular and extracellular LOXL2, leading to the critical finding that intracellular LOXL2 activity is primarily responsible for Snail upregulation and subsequent metabolic changes in HCC cells, which represents a significant advancement in understanding potential therapeutic targets for hepatocellular carcinoma.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "LOXL2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-1260z Mouse Anti-LOXL2 Recombinant Antibody (clone 19H6) WB, IP, IF, ELISA Mouse IgG2b, κ
CAT Product Name Application Type
TAB-890 Anti-Human LOXL2 Recombinant Antibody (Simtuzumab) Inhib, Agonist IgG4 - kappa
CAT Product Name Application Type
MOB-0412ZL Rabbit anti-Human LOXL2 Antibody ICC, IF, FACS, WB
CAT Product Name Application Type
TAB-0693CL Mouse Anti-LOXL2 Recombinant Antibody (TAB-0693CL) IF, ELISA, FC Mouse IgG
CAT Product Name Application Type
TAB-0693CL-S(P) Mouse Anti-LOXL2 Recombinant Antibody; scFv Fragment (TAB-0693CL-S(P)) ELISA, FC Mouse scFv
CAT Product Name Application Type
TAB-0693CL-F(E) Mouse Anti-LOXL2 Recombinant Antibody; Fab Fragment (TAB-0693CL-F(E)) ELISA, FC Mouse Fab
CAT Product Name Application Type
MOR-2075 Hi-Affi™ Recombinant Rabbit Anti-LOXL2 Monoclonal Antibody (DS2075AB) ICC, IF, FC, WB IgG
CAT Product Name Application Type
HPAB-0161-LSX Human Anti-LOXL2 Recombinant Antibody (HPAB-0161-LSX) ELISA, WB, RIA Human IgG
CAT Product Name Application Type
HPAB-0162-LSX Mouse Anti-LOXL2 Recombinant Antibody (HPAB-0162-LSX) ELISA, WB, RIA Mouse IgG
CAT Product Name Application Type
HPAB-0161-LSX-S(P) Human Anti-LOXL2 Recombinant Antibody; scFv Fragment (HPAB-0161-LSX-S(P)) ELISA, WB, RIA Human scFv
CAT Product Name Application Type
HPAB-0162-LSX-S(P) Mouse Anti-LOXL2 Recombinant Antibody; scFv Fragment (HPAB-0162-LSX-S(P)) ELISA, WB, RIA Mouse scFv
CAT Product Name Application Type
HPAB-0161-LSX-F(E) Human Anti-LOXL2 Recombinant Antibody; Fab Fragment (HPAB-0161-LSX-F(E)) ELISA, WB, RIA Human Fab
CAT Product Name Application Type
HPAB-0162-LSX-F(E) Mouse Anti-LOXL2 Recombinant Antibody; Fab Fragment (HPAB-0162-LSX-F(E)) ELISA, WB, RIA Mouse Fab
CAT Product Name Application Type
HPAB-0163-LSX Mouse Anti-LOXL2 Recombinant Antibody (HPAB-0163-LSX) ELISA, WB, RIA Mouse IgG
CAT Product Name Application Type
HPAB-0163-LSX-S(P) Mouse Anti-LOXL2 Recombinant Antibody; scFv Fragment (HPAB-0163-LSX-S(P)) ELISA, WB, RIA Mouse scFv
CAT Product Name Application Type
HPAB-0163-LSX-F(E) Mouse Anti-LOXL2 Recombinant Antibody; Fab Fragment (HPAB-0163-LSX-F(E)) ELISA, WB, RIA Mouse Fab
CAT Product Name Application Type
AFC-TAB-890 Afuco™ Anti-LOXL2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-890) FC, IP, ELISA, Neut, FuncS ADCC enhanced antibody
CAT Product Name Application Type
VS-0325-XY1256 Anti-LOXL2 Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0425-FY144 Human Anti-LOXL2 (clone Simtuzumab) scFv-Fc Chimera Inhib Human IgG4, scFv-Fc
CAT Product Name Application Type
VS-0525-XY4072 Anti-Mouse LOXL2 Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0525-XY4071 Anti-Human LOXL2 Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0525-XY4073 Anti-Rat LOXL2 Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0625-YC209 Recombinant Anti-LOXL2 Eliminating Antibody, pH-Sensitive (VS-0625-YC209) Antigen-Sweeping In Vivo. Human IgG4 kappa
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare